Immunoglobulin Igg4 (230-proline)

Immunoglobulin Igg4 (230-proline) Uses, Dosage, Side Effects, Food Interaction and all others data.

Immunoglobulin Igg4 (230-proline) is under investigation in clinical trial NCT03546907 (Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-il-33 Mab) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)).

Trade Name Immunoglobulin Igg4 (230-proline)
Generic Itepekimab
Itepekimab Other Names Immunoglobulin igg4 (230-proline), anti-(human interleukin 33) (human monoclonal regn3500 .gamma.4-chain), disulfide with human monoclonal regn3500 .kappa.-chain, dimer, Itepekimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Immunoglobulin Igg4 (230-proline)
Immunoglobulin Igg4 (230-proline)

Innovators Monograph

You find simplified version here Immunoglobulin Igg4 (230-proline)


*** Taking medicines without doctor's advice can cause long-term problems.
Share